Predictors of 25(OH)D Half-life and Plasma 25(OH)D Concentration in The Gambia and the UK

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2014 Oct 4

PMID 25278297

Citations 21

Authors

K S Jones

S Assar

D Vanderschueren

R Bouillon

A Prentice

I Schoenmakers

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Predictors of 25(OH)D3 half-life were factors associated with vitamin D metabolism, but were different between people in The Gambia and the UK. Country was the strongest predictor of plasma 25(OH)D concentration, probably as a marker of UVB exposure. 25(OH)D3 half-life may be applied as a tool to investigate vitamin D expenditure.

Introduction: The aim of this study was to investigate predictors of 25(OH)D3 half-life and plasma 25(OH)D concentration.

Methods: Plasma half-life of an oral tracer dose of deuterated-25(OH)D3 was measured in healthy men aged 24-39 years, resident in The Gambia, West Africa (n = 18) and in the UK during the winter (n = 18), countries that differ in calcium intake and vitamin D status. Plasma and urinary markers of vitamin D, calcium, phosphate and bone metabolism, nutrient intakes and anthropometry were measured.

Results: Normally distributed data are presented as mean (SD) and non-normal data as geometric mean (95% CI). Gambian compared to UK men had higher plasma concentrations of 25(OH)D (69 (13) vs. 29 (11) nmol/L; P < 0.0001); 1,25(OH)2D (181 (165, 197) vs. 120 (109, 132) pmol/L; P < 0.01); and parathyroid hormone (PTH) (50 (42, 60) vs. 33 (27, 39); P < 0.0001). There was no difference in 25(OH)D3 half-life (14.7 (3.5) days vs. 15.6 (2.5) days) between countries (P = 0.2). In multivariate analyses, 25(OH)D, 1,25(OH)2D, vitamin D binding protein and albumin-adjusted calcium (Caalb) explained 79% of variance in 25(OH)D3 half-life in Gambians, but no significant predictors were found in UK participants. For the countries combined, Caalb, PTH and plasma phosphate explained 39 % of half-life variability. 1,25(OH)2D, weight, PTH and country explained 81% of variability in 25(OH)D concentration; however, country alone explained 74%.

Conclusion: Factors known to affect 25(OH)D metabolism predict 25(OH)D3 half-life, but these differed between countries. Country predicted 25(OH)D, probably as a proxy measure for UVB exposure and vitamin D supply. This study supports the use of 25(OH)D half-life to investigate vitamin D metabolism.

Citing Articles

Longitudinal analysis of vitamin D levels considering sunshine duration and suggestion for a standardised approach for vitamin D supplementation in children and adolescents with obesity.

Wechsung K, Schnabel D, Wiegand S BMC Pediatr. 2024; 24(1):337.

PMID: 38750418 PMC: 11094954. DOI: 10.1186/s12887-024-04823-x.

Effects of intermittent overload doses of oral vitamin D3 on serum 25(OH)D concentrations and the incidence rates of fractures, falls, and mortality in elderly individuals: A systematic review and meta-analysis.

Tao X, Yang W, Zhang Q, Wang Y, Gao F, Wang Y Biomol Biomed. 2024; 24(5):1068-1076.

PMID: 38615341 PMC: 11379009. DOI: 10.17305/bb.2024.10449.

Sex-specific associations between cardiovascular risk factors and physical function: the Gambian Bone and Muscle Ageing Study.

Zengin A, Breasail M, Parsons C, Jarjou L, Janha R, Jobe M J Cachexia Sarcopenia Muscle. 2022; 14(1):84-92.

PMID: 36346161 PMC: 9891990. DOI: 10.1002/jcsm.13069.

Particulate matter may have a limited influence on maternal vitamin D levels.

Li C, Gong Y, Xia Y, Wang X, Chen L, Yan S Sci Rep. 2022; 12(1):16807.

PMID: 36207476 PMC: 9546910. DOI: 10.1038/s41598-022-21383-1.

Mediation Effects of IL-1β and IL-18 on the Association Between Vitamin D Levels and Mild Cognitive Impairment Among Chinese Older Adults: A Case-Control Study in Taiyuan, China.

Cheng L, Dong R, Song C, Li X, Zhang L, Shi M Front Aging Neurosci. 2022; 14:836311.

PMID: 35370605 PMC: 8966426. DOI: 10.3389/fnagi.2022.836311.

References

Jones K, Schoenmakers I, Bluck L, Ding S, Prentice A . Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults. Br J Nutr. 2011; 107(8):1128-37. PMC: 3328847. DOI: 10.1017/S0007114511004132. View

Brown A, Dusso A, Slatopolsky E . Vitamin D. Am J Physiol. 1999; 277(2):F157-75. DOI: 10.1152/ajprenal.1999.277.2.F157. View

Fitt E, Cole D, Ziauddeen N, Pell D, Stickley E, Harvey A . DINO (Diet In Nutrients Out) - an integrated dietary assessment system. Public Health Nutr. 2014; 18(2):234-41. PMC: 4862572. DOI: 10.1017/S1368980014000342. View

Mawer E, Schaefer K, LUMB G, STANBURY S . The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. Clin Sci. 1971; 40(1):39-53. DOI: 10.1042/cs0400039. View

Young K, Engelman C, Langefeld C, Hairston K, Haffner S, Bryer-Ash M . Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab. 2009; 94(9):3306-13. PMC: 2741711. DOI: 10.1210/jc.2009-0079. View

Anderson P, Lee A, Anderson S, Sawyer R, OLoughlin P, Morris H . The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels. J Steroid Biochem Mol Biol. 2010; 121(1-2):288-92. DOI: 10.1016/j.jsbmb.2010.03.022. View

Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R . Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester). 2010; 16(1):81-9. DOI: 10.1255/ejms.1024. View

Clements M, Davies M, Fraser D, LUMB G, Mawer E, Adams P . Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond). 1987; 73(6):659-64. DOI: 10.1042/cs0730659. View

Prentice A, Goldberg G, Schoenmakers I . Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008; 88(2):500S-506S. DOI: 10.1093/ajcn/88.2.500S. View

10.

Braithwaite V, Jones K, Assar S, Schoenmakers I, Prentice A . Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children. Endocr Connect. 2013; 3(1):1-10. PMC: 3869962. DOI: 10.1530/EC-13-0070. View

11.

Vicchio D, Yergey A, OBrien K, Allen L, Ray R, Holick M . Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom. 1993; 22(1):53-8. DOI: 10.1002/bms.1200220107. View

12.

Bouillon R, Van Baelen H, DE MOOR P . Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem. 1980; 13(9):1029-34. DOI: 10.1016/0022-4731(80)90133-8. View

13.

Haddock L, Vazquez M, Rivera R, Corcino J . The kinetics of D3-3H metabolism in tropical sprue. P R Health Sci J. 1985; 4(1):47-56. View

14.

Vanderschueren D, Pye S, ONeill T, Lee D, Jans I, Billen J . Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2013; 98(3):995-1005. DOI: 10.1210/jc.2012-2772. View

15.

Clements M, Johnson L, Fraser D . A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature. 1987; 325(6099):62-5. DOI: 10.1038/325062a0. View

16.

Clements M, Davies M, Hayes M, Hickey C, LUMB G, Mawer E . The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol (Oxf). 1992; 37(1):17-27. DOI: 10.1111/j.1365-2265.1992.tb02278.x. View

17.

Jones K, Assar S, Harnpanich D, Bouillon R, Lambrechts D, Prentice A . 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab. 2014; 99(9):3373-81. PMC: 4207933. DOI: 10.1210/jc.2014-1714. View

18.

Gray R, Weber H, Dominguez J, LEMANN Jr J . The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans. J Clin Endocrinol Metab. 1974; 39(6):1045-56. DOI: 10.1210/jcem-39-6-1045. View

19.

Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer H . Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29(6):726-76. PMC: 2583388. DOI: 10.1210/er.2008-0004. View

20.

Schoenmakers I, Jarjou L, Goldberg G, Tsoi K, Harnpanich D, Prentice A . Acute response to oral calcium loading in pregnant and lactating women with a low calcium intake: a pilot study. Osteoporos Int. 2013; 24(8):2301-8. PMC: 3706729. DOI: 10.1007/s00198-013-2280-2. View